Treatment of stage II and III early breast cancer is based on combinations of surgery, radiation therapy, endocrine therapy for estrogen receptor positive cases, trastuzumab for HER2 (human epidermal growth factor receptor 2)-positive tumors, and cytotoxic chemotherapy. This evidence concerns the gene ERBB2 and breast carcinoma.